These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32673357)

  • 1. Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection.
    Nemeth J; Olson GS; Rothchild AC; Jahn AN; Mai D; Duffy FJ; Delahaye JL; Srivatsan S; Plumlee CR; Urdahl KB; Gold ES; Aderem A; Diercks AH
    PLoS Pathog; 2020 Jul; 16(7):e1008655. PubMed ID: 32673357
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.
    Urdahl KB
    Semin Immunol; 2014 Dec; 26(6):578-87. PubMed ID: 25453230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway Macrophages Mediate Mucosal Vaccine-Induced Trained Innate Immunity against
    D'Agostino MR; Lai R; Afkhami S; Khera A; Yao Y; Vaseghi-Shanjani M; Zganiacz A; Jeyanathan M; Xing Z
    J Immunol; 2020 Nov; 205(10):2750-2762. PubMed ID: 32998983
    [No Abstract]   [Full Text] [Related]  

  • 9. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.
    Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P
    EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.
    Li X; Xu W; Xiong S
    Clin Vaccine Immunol; 2012 May; 19(5):723-30. PubMed ID: 22461526
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ryndak MB; Laal S
    Front Cell Infect Microbiol; 2019; 9():299. PubMed ID: 31497538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
    Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
    J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection.
    Mai D; Jahn A; Murray T; Morikubo M; Lim PN; Cervantes MM; Pham LK; Nemeth J; Urdahl K; Diercks AH; Aderem A; Rothchild AC
    PLoS Pathog; 2024 Jan; 20(1):e1011871. PubMed ID: 38236787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
    Leroux-Roels I; Forgus S; De Boever F; Clement F; Demoitié MA; Mettens P; Moris P; Ledent E; Leroux-Roels G; Ofori-Anyinam O;
    Vaccine; 2013 Apr; 31(17):2196-206. PubMed ID: 22643213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
    Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.
    Ahmed M; Smith DM; Hamouda T; Rangel-Moreno J; Fattom A; Khader SA
    Vaccine; 2017 Sep; 35(37):4983-4989. PubMed ID: 28774560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
    Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
    Monin L; Griffiths KL; Slight S; Lin Y; Rangel-Moreno J; Khader SA
    Mucosal Immunol; 2015 Sep; 8(5):1099-109. PubMed ID: 25627812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of M. Tuberculosis-derived IL-12-inducing material by alveolar macrophages.
    Higuchi K; Sekiya Y; Harada N
    Vaccine; 2004 Jan; 22(5-6):724-34. PubMed ID: 14741165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.